Contents Other books @ NCBI

  Note: only Chapter 6: Smallpox and Vaccinia, is available for this book. To search this chapter, type a term into the box on the right.  

INTRODUCTION

1. A Short History of Vaccination
Susan L. Plotkin and Stanley A. Plotkin

2. The History of Polio Vaccine Development
Frederick C. Robbins

3. The Immunology of Vaccination
Gordon Ada

4. Overview of Vaccine Manufacturing and Quality Assurance
Gary B. Ebbert, Eugene D. Mascolo and Howard R. Six

5. General Immunization Practices
John C. Watson and Georges Peter

6. Smallpox and Vaccinia
Donald A. Henderson and Bernard Moss.

7. Immunization in the Immunocompromised Host
Per Ljungman

LICENSED VACCINES

8. Bacille Calmette-Guérin Vaccine
Kim Connelly Smith and Jeffrey R. Starke

9. Diphtheria Toxoid
Edward A. Mortimer Jr. and Melinda Wharton

10. Hepatitis B Vaccine
Francis J. Mahoney and Mark Kane

11. Haemophilus influenzae Vaccines
Joel I. Ward and Kenneth M. Zangwill

12. Measles Vaccine
Stephen C. Redd, Lauri E. Markowitz and Samuel L. Katz

13. Mumps Vaccine
Stanley A. Plotkin and Melinda Wharton

14. Pertussis Vaccine
Kathryn M. Edwards, Michael D. Decker and Edward A. Mortimer Jr.

15. Inactivated Polio Vaccine
Stanley A. Plotkin, Andrew D. Murdin and Emmanuel Vidor

16. Live Attenuated Poliovirus Vaccines
Roland W. Sutter, Stephen L. Cochi and Joseph L. Melnick

17. Rubella Vaccine
Stanley A. Plotkin

18. Tetanus Toxoid
Steven G. F. Wassilak , Walter A. Orenstein and Roland W. Sutter

19. Varicella Vaccine
Anne A. Gershon, Michiaki Takahashi and C. Jo White

20. Combination Vaccines
Michael D. Decker and Kathryn M. Edwards

VACCINES RECOMMENDED FOR ADULTS

21. Inactivated Influenza Vaccines
Edwin D. Kilbourne and Nancy H. Arden

22. Pneumococcal Vaccine
David S. Fedson, Daniel M. Musher and Juhani Eskola

VACCINES FOR SPECIAL RISK GROUPS AND SELECTED GEOGRAPHICAL AREAS

23. Adenovirus Vaccines
Charlotte A. Gaydos and Joel C. Gaydos

24. Anthrax
Philip S. Brachman and Arthur M. Friedlander

25. Cholera Vaccines
David A. Sack and Michel Cadoz

26. Hepatitis A Vaccine
Stephen M. Feinstone and Ian D. Gust

27. Japanese Encephalitis Vaccines
Theodore F. Tsai, Gwong-Jen J. Chang and Yong Xin Yu

28. Meningococcal Vaccines
Martha L. Lepow, Bradley A. Perkins, Patricia A. Hughes and Jan T. Poolman

29. Miscellaneous Limited-Use Vaccines
George R. French and Stanley A. Plotkin

30. Plague
Richard W. Titball, Stephen Eley, Diane E. Williamson and David T. Dennis

31. Rabies Vaccine
Stanley A. Plotkin, Charles E. Rupprecht and Hilary Koprowski

32. Tick-Borne Encephalitis Vaccine
Noel P. Barrett, Friedrich Dorner and Stanley A. Plotkin

33. Typhoid Fever Vaccines
Myron M. Levine

34. Yellow Fever
Thomas P. Monath

SELECTED VACCINES OF THE FUTURE

35. New Technologies for Making Vaccines
Ronald W. Ellis

36. Cytomegalovirus Vaccines
Stanley A. Plotkin

37. Live Influenza Virus Vaccine
Hunein F. Maassab, Louise M. Herlocher and Martin L. Bryant

38. Human Immunodeficiency Virus
Marc P. Girard and Jean-Louis Excler

39. Lyme Disease Vaccine
Janine Evans and Erol Fikrig

40. Parasitic Disease Vaccines
Peter J. Hotez

41. Rotavirus Vaccines
Fred H. Clark, Roger I. Glass and Paul A. Offit

PUBLIC HEALTH AND REGULATORY ISSUES

42. Public Health Considerations - United States
Walter A. Orenstein, Alan R. Hinman and Lance E. Rodewald

43. Immunization in Europe
David M. Salisbury and Sieghart Dittmann

44. Vaccination Programs in Developing Countries
Felicity T. Cutts and Jean-Marc Olivé

45. Cost-Benefit and Cost-Effectiveness Analysis of Vaccine Policy
Mark A. Miller and Alan R. Hinman

46. Vaccines for International Travel
Elizabeth Day Barnett, Robert T. Chen and Michel Rey

47. Vaccines for Healthcare Workers
David J. Weber, Kristen Weigle and William A. Rutala

48. Regulation and Testing of Vaccines
Paul D. Parkman and Carolyn M. Hardegree

49. Safety of Vaccines
Robert T. Chen

50. U.S. Law
Edmund W. Kitch, Geoffrey Evans and Robyn Gopin

EPILOGUE

Appendix 1. Recommendations of the Advisory Committee on Immunization Practices

Appendix 2. Immunobiologicals and Their Manufacturers and Distributors

Appendix 3. Representative Vaccine Information Statement (VIS)

Appendix 4. Case Definitions for Selected VaccinePreventable Diseases Under Public Health Surveillance in the United States